PIAS3 expression in squamous cell lung cancer is low and predicts overall survival

Unlike lung adenocarcinoma, little progress has been made in the treatment of squamous cell lung carcinoma (SCC). The Cancer Genome Atlas (TCGA) has recently reported that receptor tyrosine kinase signaling pathways are altered in 26% of SCC tumors, validating the importance of downstream Signal Tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbas, Rime, McColl, Karen S, Kresak, Adam, Yang, Michael, Chen, Yanwen, Fu, Pingfu, Wildey, Gary, Dowlati, Afshin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380958/
https://www.ncbi.nlm.nih.gov/pubmed/25573684
http://dx.doi.org/10.1002/cam4.372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380958/
https://www.ncbi.nlm.nih.gov/pubmed/25573684
http://dx.doi.org/10.1002/cam4.372

Ejemplares similares